Cargando…
Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR–RUNX1
Tumor-derived factors are thought to regulate thrombocytosis and erythrocytopenia in individuals with cancer; however, such factors have not yet been identified. Here we show that tumor cell-released kynurenine (Kyn) biases megakaryocytic–erythroid progenitor cell (MEP) differentiation into megakary...
Autores principales: | Zhou, Li, Wu, Dongxiao, Zhou, Yabo, Wang, Dianheng, Fu, Haixia, Huang, Qiusha, Qin, Guohui, Chen, Jie, Lv, Jiadi, Lai, Shaoyang, Zhang, Huafeng, Tang, Ke, Ma, Jingwei, Fiskesund, Roland, Zhang, Yi, Zhang, Xiaohui, Huang, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10681900/ https://www.ncbi.nlm.nih.gov/pubmed/37919525 http://dx.doi.org/10.1038/s41590-023-01662-3 |
Ejemplares similares
-
Publisher Correction: Tumor cell-released kynurenine biases MEP differentiation into megakaryocytes in individuals with cancer by activating AhR–RUNX1
por: Zhou, Li, et al.
Publicado: (2023) -
Blockade of IDO-kynurenine-AhR metabolic circuitry abrogates IFN-γ-induced immunologic dormancy of tumor-repopulating cells
por: Liu, Yuying, et al.
Publicado: (2017) -
The Role of the Kynurenine/AhR Pathway in Diseases Related to Metabolism and Cancer
por: Shadboorestan, Amir, et al.
Publicado: (2023) -
The biological interactions between kynurenine and AhR in melanocytes: in vitro studies
por: Walczak, Katarzyna, et al.
Publicado: (2023) -
Mucus production stimulated by IFN-AhR signaling triggers hypoxia of COVID-19
por: Liu, Yuying, et al.
Publicado: (2020)